Back to top

Jefferies Reaffirms Their Buy Rating on Xenon (XENE)

Jefferies analyst Andrew Tsai maintained a Buy rating on Xenon today and set a price target of $65.00. The company’s shares closed yesterday at $35...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Xenon Pharmaceuticals Inc. (XENE)